openPR Logo
Press release

Dengue Vaccine Market Report Analysis, Research Studies | Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd

07-10-2024 07:32 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Dengue Vaccine Market Report Analysis, Research Studies |

DataM Intelligence has published a new research report on "Dengue Vaccine Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/dengue-vaccine-market

The Dengue Vaccine market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

The Dengue Vaccine Market refers to the global industry focused on the research, development, production, and distribution of vaccines designed to prevent dengue fever, a mosquito-borne viral infection caused by the dengue virus. This market includes vaccines targeting multiple serotypes of the dengue virus, which can cause severe flu-like symptoms and, in some cases, lead to life-threatening complications such as dengue hemorrhagic fever or dengue shock syndrome. The market is driven by the global burden of dengue, particularly in tropical and subtropical regions, and efforts to reduce transmission through vaccination programs. Key players in this market include pharmaceutical companies, research institutions, and public health organizations working towards effective prevention strategies against dengue fever.

Forecast Growth Projected:

The Global Dengue Vaccine Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Dengue Vaccine Market:

Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd, Vabiotec, Panacea Biotec and Medigen Biologics.

Segment Covered in the Dengue Vaccine Market:

By Product Type: CYD-TDV

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others

Regional Analysis:

The global Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/dengue-vaccine-market

Regional Analysis:

The global Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Dengue Vaccine Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Dengue Vaccine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Dengue Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/dengue-vaccine-market

FAQs

How fast is the Dengue Vaccine Market growing?

The Dengue Vaccine Market will exhibit a CAGR of 10.4% during the forecast period, 2024-2031.

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dengue Vaccine Market Report Analysis, Research Studies | Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd here

News-ID: 3573377 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States LCP Films and Laminates Market Size, Share, Trends, Growth Drivers, Competitive Landscape, and Forecast (2024-2031)
United States LCP Films and Laminates Market Size, Share, Trends, Growth Drivers …
Market Size and Growth The global LCP (Liquid Crystal Polymer) Films & Laminates Market is estimated to witness significant growth during the forecast period (2024-2031), driven by increasing demand across electronics, automotive, aerospace, and industrial applications. Download Free Sample Report: https://www.datamintelligence.com/download-sample/lcp-films-and-laminates-market?Juli Recent Industry Developments United States: ✅Strong surge in LCP film demand in the U.S., driven by 5G infrastructure rollouts and increasing use in high-frequency antennas. ✅LCP manufacturers are collaborating with U.S.-based
Global Cold-Pressed Coconut Oil Market to Reach US$ 5.53B by 2031:Organic, Virgin, and Healthy Oil Trends Driving 7.5% CAGR Growth
Global Cold-Pressed Coconut Oil Market to Reach US$ 5.53B by 2031:Organic, Virgi …
Market Size and Growth Global Cold-Pressed Coconut Oil Market reached US$ 3.10 billion in 2023 and is expected to reach US$ 5.53 billion by 2031, growing with a CAGR of 7.5% during the forecast period 2024-2031. Key Development: United States: Recent Cold‐Pressed Coconut Oil Developments ✅ In October 2025, Kakaku listed COCO GARDEN's cold‐pressed, organic, no‐additive coconut oil as a top-selling 無農薬 (pesticide-free) product in Japan highlighting premiumization in domestic retail. ✅ In September
United States Industrial Cleaning Chemicals Market valuation US$ 20.07 Billion by 2031 - Exclusive Report by DataM Intelligence
United States Industrial Cleaning Chemicals Market valuation US$ 20.07 Billion b …
Leander, Texas and TOKYO, Japan - Nov. 20. 2025 Global Industrial Cleaning Chemicals Market reached US$ 47 Billion and is expected to reach US$ 66.9 Billion by 2030, growing with a CAGR of 4.5 % during the forecast period 2024-2031. As per DataM Intelligence research report. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/industrial-cleaning-chemicals-market?praveen United States: Recent Industry Developments ✅ March 2025 - The Environmental Protection Agency (EPA) enforced stricter
United States Nitrocellulose Market Report 2024-2031: Size, Share, Growth, Drivers, Opportunities, Industry Analysis, and Future Outlook
United States Nitrocellulose Market Report 2024-2031: Size, Share, Growth, Drive …
Market Size and Growth The global Nitrocellulose Market is projected to grow at a CAGR of 6.02% during the forecast period (2023-2030). Growth is primarily driven by the rising demand from the construction industry in the Asia-Pacific region, where nitrocellulose is widely used in coatings, paints, adhesives, and surface finishes. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/nitrocellulose-market?Juli Recent Industry Developments United States:

All 5 Releases


More Releases for Dengue

Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth? The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate? In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,
Dengue Vaccine Market : An Detailed Overview
Introduction: Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the
Dengue Vaccine Market : An Overview
Introduction: Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual. It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240 The report provides a comprehensive analysis of company profiles listed below: - Sanofi - Takeda Dengue Vaccines Market Segment by